BEAM
Price
$25.96
Change
+$0.17 (+0.66%)
Updated
Oct 17, 04:59 PM (EDT)
Capitalization
2.61B
24 days until earnings call
CAPR
Price
$6.24
Change
+$0.08 (+1.30%)
Updated
Oct 17, 04:59 PM (EDT)
Capitalization
281.62M
26 days until earnings call
Interact to see
Advertisement

BEAM vs CAPR

Header iconBEAM vs CAPR Comparison
Open Charts BEAM vs CAPRBanner chart's image
Beam Therapeutics
Price$25.96
Change+$0.17 (+0.66%)
Volume$22.27K
Capitalization2.61B
Capricor Therapeutics
Price$6.24
Change+$0.08 (+1.30%)
Volume$37.81K
Capitalization281.62M
BEAM vs CAPR Comparison Chart in %
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CAPR commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and CAPR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (BEAM: $25.79 vs. CAPR: $6.16)
Brand notoriety: BEAM and CAPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 88% vs. CAPR: 100%
Market capitalization -- BEAM: $2.61B vs. CAPR: $281.62M
BEAM [@Biotechnology] is valued at $2.61B. CAPR’s [@Biotechnology] market capitalization is $281.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileCAPR’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • CAPR’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than CAPR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 2 TA indicator(s) are bullish while CAPR’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 2 bullish, 5 bearish.
  • CAPR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CAPR is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -7.46% price change this week, while CAPR (@Biotechnology) price change was -19.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.26%. For the same industry, the average monthly price growth was +15.62%, and the average quarterly price growth was +78.54%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

CAPR is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+1.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.61B) has a higher market cap than CAPR($282M). BEAM YTD gains are higher at: 3.992 vs. CAPR (-55.362). CAPR has higher annual earnings (EBITDA): -71.78M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. CAPR (123M). CAPR has less debt than BEAM: CAPR (1.04M) vs BEAM (155M). BEAM has higher revenues than CAPR: BEAM (60.3M) vs CAPR (13.4M).
BEAMCAPRBEAM / CAPR
Capitalization2.61B282M925%
EBITDA-414.33M-71.78M577%
Gain YTD3.992-55.362-7%
P/E RatioN/AN/A-
Revenue60.3M13.4M450%
Total Cash1.15B123M935%
Total Debt155M1.04M14,847%
FUNDAMENTALS RATINGS
CAPR: Fundamental Ratings
CAPR
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCAPR
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 16 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPCCY60.380.44
+0.73%
PICC Property and Casualty Co., Ltd.
ADVOF24.19N/A
N/A
ADVA AG Optical Networking
CIBEY2.06N/A
N/A
Commercial International Bank Ltd.
PRSEF4.95N/A
N/A
Prosafe SE (Cyprus)
EVTK2.50-0.01
-0.40%
Eventiko Inc.

CAPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAPR has been loosely correlated with BEAM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CAPR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAPR
1D Price
Change %
CAPR100%
-7.92%
BEAM - CAPR
35%
Loosely correlated
-5.15%
RGNX - CAPR
34%
Loosely correlated
+0.33%
ACLX - CAPR
34%
Loosely correlated
-3.81%
XNCR - CAPR
33%
Loosely correlated
+6.03%
AURA - CAPR
33%
Poorly correlated
-2.52%
More